Riskpilot← Back to searchSign inGet full accessMedivatus Group ApS
APSActiveCVR 40644482Gnisten 2, 1. thWholesale of pharmaceutical and medical goods · NACE 4646Est. 20191 employeeswww.medivatus.com
Revenue 2024
DKK 0
EBITDA margin
—
+25% vs 2023
Equity ratio
99.3%
Financial strength
Net profit 2024
DKK -297K
+12% vs 2023
| Revenue | DKK 0 | — |
| EBITDA | DKK -325K | +25% |
| Net profit | DKK -297K | +12% |
| Total assets | DKK 577K | -39% |
| Equity | DKK 573K | -34% |
| Employees | 1 | — |
Legal name
Medivatus Group ApS
CVR number
40644482
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
2. juli 2019
Share capital
DKK 50.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren
Company purpose
Selskabets formål er at eje andre selskaber og hermed beslægtet virksomhed
Address
Gnisten 2, 1. th
Phone
+4523640288
Email
edoc@medivatus.com
Website
www.medivatus.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 400 | 1.778 | 958 | 34 | 0 |
| Staff expenses | -0 | -428 | -1.178 | -766 | -12 | -0 |
| EBITDA | -6 | -277 | -95 | 2 | -433 | -325 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -6 | -277 | -95 | 2 | -433 | -325 |
| Net financials | 153 | 939 | -2.096 | 2.079 | 96 | 27 |
| Profit before tax | 146 | 704 | -2.192 | 2.081 | -336 | -297 |
| Tax | -2 | -0 | -0 | 0 | -0 | -0 |
| Net profit | 148 | 704 | -2.192 | 2.080 | -336 | -297 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 778 | 2.012 | 2.962 | 1.642 | 943 | 577 |
| Equity | 605 | 1.309 | -883 | 1.206 | 870 | 573 |
| Long-term debt | 173 | 703 | 2.920 | 418 | 73 | 4 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Total debt | 173 | 703 | 2.920 | 418 | 73 | 4 |
EBITDA margin
-32458900.0%
This company
15.8%
Market median
-205436176% vs market
20192024
Equity ratio
99.3%
This company
38.2%
Market median
+160% vs market
20192024
Return on equity
-51.9%
This company
18.4%
Market median
-382% vs market
20192024
Net profit margin
-29726100.0%
This company
8.1%
Market median
-366988989% vs market
20192024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20192024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-07-02 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
OØ Management | Management | 2019 | — | — |
DG Management | Management | 2020 | — | — |
HK Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2022 | |
| Individual | 5.0% | 5.0% | 2019 | |
| Individual | 5.0% | 5.0% | 2019 | |
| Individual | 5.0% | 5.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Medivatus Group ApS 
BOFFICE DANMARK ApSBoard members of Medivatus Group ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Odd Øyvind Carlsvig | Management | 0 companies |
| David Gareth Martin | Management | 0 companies |
| Helle Katrine Jørgensen | Chief Executive Officer | 0 companies |
| Niels Erik Feilberg | Chairman | 0 companies |